JiangSu WuZhong Pharmaceutical Development Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021
October 28, 2021 at 03:45 am EDT
Share
JiangSu WuZhong Pharmaceutical Development Co., Ltd. reported earnings results for the nine months ended September 30, 2021. For the nine months, the company reported sales was CNY 1,467.78 million compared to CNY 1,480.9 million a year ago. Revenue was CNY 1,467.78 million compared to CNY 1,480.9 million a year ago. Net income was CNY 49.39 million compared to net loss of CNY 45.96 million a year ago. Basic earnings per share from continuing operations was CNY 0.069 compared to basic loss per share from continuing operations of CNY 0.065 a year ago. Diluted earnings per share from continuing operations was CNY 0.069 compared to diluted loss per share from continuing operations of CNY 0.065 a year ago.
JiangSu WuZhong Pharmaceutical Development Co Ltd, formerly Jiangsu Wuzhong Industrial Co Ltd, is a China-based company mainly engaged in pharmaceutical business. The Company's business includes pharmaceuticals, chemicals and real estate. Pharmaceutical business mainly involves pharmaceutical research, development, manufacture and sales. Chemical business mainly includes research, development, manufacture and sales of organic pigments, dyes and intermediates. Its main production varieties are used to produce reactive dyes and organic pigments. Real estate business includes commercial housing and affordable housing.